ArticleFrontiers in neuroscience2023

Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study.

Alessandro Maria Berton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.